Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06269666 · ClinicalTrials.gov registry record · NA
P200TxE Diseased Eye Image Collection
A NA study of Retinal Disease, sponsored by Optos.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06269666: Recruiting NA study of Retinal Disease, sponsored by Optos.
NCT06269666 is a NA study of Retinal Disease that is actively recruiting participants, run by Optos. The registered enrollment target is 100 participants, below the 1,236-participant average among 19 other Retinal Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06269666, a NA study of Retinal Disease, is actively recruiting participants, sponsored by Optos.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to collect images on the P200TxE device in diseased eyes.
Conditions Studied
Interventions
- DEVICE P200TxE
Study Locations (1)
Kentucky
- Bennett and Bloom Eye Centers - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
What NCT06269666 shows while recruiting
NCT06269666 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,236-participant average among 19 other Retinal Disease trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Retinal Disease appearing as the primary indexed condition, and to 1 intervention - of which P200TxE is the first listed.
NCT06269666 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06269666 about?
NCT06269666 is a clinical study titled "P200TxE Diseased Eye Image Collection". The primary objective is to collect images on the P200TxE device in diseased eyes.
What is the current status of trial NCT06269666?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-01-31. Estimated completion is 2024-12-01.
What conditions does trial NCT06269666 study?
This clinical trial studies the following conditions: Retinal Disease.
What interventions are being tested in trial NCT06269666?
The interventions under investigation include: P200TxE (DEVICE).
Who is sponsoring clinical trial NCT06269666?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06269666 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06269666's enrollment target sits among peer trials
100 9th of 19 higher than 11 of 19 other Retinal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
RECRUITING
-
Data Gathering for A10900
RECRUITING
-
Inherited Retinal Degenerative Disease Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI